Solid Biosciences
Solid Biosciences Logo
About Solid Biosciences
Solid Biosciences Inc is a biotechnology company focused on developing precision genetic medicines for rare neuromuscular and cardiac diseases. Its pipeline includes gene therapy candidates targeting Duchenne muscular dystrophy, Friedreich’s ataxia, catecholaminergic polymorphic ventricular tachycardia, TNNT2-mediated and BAG3-mediated dilated cardiomyopathy, and other rare cardiac conditions. The company also develops platform technologies such as capsid libraries and dual gene expression systems to advance gene therapy delivery. Solid Biosciences collaborates with academic institutions and industry partners to bring transformative therapies to patients.
Address
500 Rutherford Avenue, Third Floor
Charlestown, 02129
United States
Year founded
2013
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
